ReachRxResearch
Home
Research
Sign Up
Clinical and metabolic subtypes of recent-onset adult type 1 diabetes: a prospective cohort study
Back to Research Hub
  1. Home
  2. Research Hub
  3. Clinical and metabolic subtypes of recen…

Clinical and metabolic subtypes of recent-onset adult type 1 diabetes: a prospective cohort study

The Lancet Diabetes & Endocrinology·October 30Open Access
Endocrinology & MetabolismPractice changingType 1 DiabetesProspective Cohort StudyAutoantibody TestingMachine Learning Disease SubtypingPolygenic Risk ScoreAdult

Summary

View source

What was studied

This prospective cohort study used unsupervised machine learning to identify clinical and metabolic subtypes of recent-onset adult type 1 diabetes (within 12 months of diagnosis, aged 18–69 years) in the German Diabetes Study (n=600, mean follow-up 6.1 years), validated in the DPV registry (n=483, mean follow-up 3.1 years).

Key findings

Three subtypes were identified: classic type 1 diabetes (GADA-positive, lower BMI, higher insulin sensitivity, severe β-cell loss), mixed type 1 diabetes (GADA-positive, higher BMI, lower insulin sensitivity, better β-cell function — positioned ~6.1 years earlier on the β-cell decline trajectory), and a GADA-negative subtype with lower genetic type 1 diabetes risk. Mixed type 1 diabetes carried markedly higher retinopathy risk vs. classic type 1 diabetes (aHR 4.93, 95% CI 1.71–14.24) and differed significantly in hypoglycaemia (log-rank p=0.0019) and cardiovascular autonomic neuropathy (log-rank p=0.028) rates.

Study limitations

Machine learning clustering was based on five variables and may not capture all axes of heterogeneity; the GADA-negative subtype's lower genetic risk raises uncertainty about whether these individuals truly have autoimmune type 1 diabetes; follow-up duration varied widely (SD ~4.7–5.0 years), limiting long-term complication comparisons.

Clinical implications

Clinicians should recognise that adults with recent-onset type 1 diabetes who have higher BMI and lower insulin sensitivity (mixed type 1 diabetes) are likely at an earlier stage of β-cell decline and face higher complication risk — this group may represent a priority window for disease-modifying interventions.

Caveats

  • Findings are from predominantly European-ancestry cohorts in Germany; generalisability to other ethnicities and healthcare settings is uncertain
  • The GADA-negative subtype had lower type 1 diabetes polygenic risk scores, raising the possibility that some participants in this subtype may have been misclassified as having autoimmune type 1 diabetes clinically
  • The retinopathy hazard ratio for mixed vs. classic type 1 diabetes (aHR 4.93) is based on follow-up that averaged only ~6 years, and complication rates may shift over longer observation

Related Questions

Explore related topics

How does insulin sensitivity differ between classic and mixed adult-onset type 1 diabetes subtypes?What disease-modifying therapies are being studied for adults with recent-onset type 1 diabetes?How reliable is GADA testing for distinguishing type 1 from type 2 diabetes in adults?

Publication Details

Year
2026
Journal
The Lancet Diabetes & Endocrinology
Sample Size
n=600
Source
View article
Keep scrolling
More content below.
Up Next